TSHR and hematocrit: A recent large cross-sectional survey identified TSHR-blocking antibodies in 9.3% of HT patients but only around a half were hypothyroid; while some of the euthyroid group appear to have been taking thyroxine, others had TSHR-stimulating antibodies in addition, which may have countered the effect of TSHR blockade [42].